Crispr Therapeutics shares owned by Keynote Financial Services
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Keynote Financial Services
from 13F filings
Historical chart of Keynote Financial Services investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Keynote Financial Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Keynote Financial Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $260k | 4.8k | 54.54 |
More positions owned by Keynote Financial Services
View all positions for Keynote Financial Services